ライフサイエンスコーパス: cardiopulmonary disease

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 10% of cirrhosis patients, in the absence of cardiopulmonary disease.

2 y explaining distinct responses of the RV to cardiopulmonary disease.

3 ere aged 37, 46, and 55 yrs and had no prior cardiopulmonary disease.

4 mulations in persons > or =65 years old with cardiopulmonary disease.

5 ized as an important pathogen in adults with cardiopulmonary disease.

6 significant changes in patients with chronic cardiopulmonary disease.

7 h, or a history of venous thromboembolism or cardiopulmonary disease.

8 Healthy volunteers were screened to exclude cardiopulmonary disease.

9 ong susceptible individuals with preexisting cardiopulmonary disease.

10 se is associated with increased mortality in cardiopulmonary diseases.

11 in healthy human heart and in patients with cardiopulmonary diseases.

12 c heart disease, and those free from chronic cardiopulmonary diseases.

13 the 18 were initially misdiagnosed as other cardiopulmonary diseases.

14 n the protein is correlated with severity of cardiopulmonary diseases.

15 populations, including those with underlying cardiopulmonary diseases.

16 els adjusted for age, race, body mass index, cardiopulmonary disease, alcohol use, pacemaker, cholest

17 so that panic anxiety can reflect underlying cardiopulmonary disease and dyspnea can reflect an under

18 ho were > or =65 years old or had underlying cardiopulmonary disease and who were hospitalized with a

19 ffects, including premature mortality due to cardiopulmonary diseases and lung cancer.

20 rly adults, high-risk adults with underlying cardiopulmonary disease, and a hospitalized group.

21 conditions, including vitamin A deficiency, cardiopulmonary diseases, and hypoxia.

22 In subjects without cardiopulmonary disease (any heart failure, coronary art

23 r identify the exact role for iNO therapy in cardiopulmonary diseases associated with hypoxemia or pu

24 pulmonary arterial hypertension (IPAH) is a cardiopulmonary disease characterized by cellular prolif

25 lung injury) and increases susceptibility to cardiopulmonary disease (chronic hypoxic pulmonary hyper

26 ed into episodes of care for six conditions: cardiopulmonary disease, coronary and/or cardiac disease

27 dent on whether or not the patient has prior cardiopulmonary disease (CPD).

28 the prognostic performance of age, previous cardiopulmonary disease, D-dimer, brain natriuretic pept

29 raph or history of venous thromboembolism or cardiopulmonary disease does not appear to adversely aff

30 lved as a successful treatment for end-stage cardiopulmonary disease in children; however, clear guid

31 Heartworms can cause serious cardiopulmonary disease in their canid hosts.

32 exclusively associated with prematurity and cardiopulmonary diseases in industrialized countries, pr

33 PDE5) has attracted much interest in several cardiopulmonary diseases, in particular myocardial ische

34 Based on studies on dyspnea in cardiopulmonary diseases, including asthma and asthma-li

35 erial pressure that is not due to coexistent cardiopulmonary disease, known as pulmonary arterial hyp

36 Associations with specific cardiopulmonary diseases might be useful in exploring po

37 in elderly persons and those with underlying cardiopulmonary disease over a long duration is not well

38 Although patients with underlying cardiopulmonary disease remain at risk, most complicatio

39 sociated with increased morbidity across the cardiopulmonary disease spectrum.

40 Cardiopulmonary diseases were more common among inpatien

41 d and fifty healthy men, without diabetes or cardiopulmonary disease, were recruited from the communi

42 Hypoxia is often associated with cardiopulmonary diseases, which represent some of the le

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。